Treatment for dogs alleviates fear of noisy fireworks

November 01, 2017

With Bonfire Night approaching, many dogs suffer anxiety and fear from the loud bangs and explosions of firework displays. A study published by Veterinary Record shows how a medicinal treatment can help alleviate common fear behaviours, such as trembling and whining.

The study has won this year's Veterinary Record Impact Award for research that is considered likely to have the most significant practical impact by the journal's research editorial team.

It was selected from around 150 papers published by Veterinary Record last year, due to it's highly practical outcome for an issue often seen by vets in small animal practice.

After a rigorous judging process, the paper was commended as an important contribution to improving the welfare of both pets and owners, and for being a high-quality (double-blinded) study of the appropriate power. The innovation is now available as a treatment on prescription by vets.

Sensitivity to noise is among the most common behavioural concerns for dog owners but is often inadequately treated.

A research team, led by Dr Mira Korpivaara at Orion Pharma, developed an oral gel form of dexmedetomidine that could be administered by dog owners at home.

On New Year's Eve 2012, 182 dogs with a history of acute anxiety and fear associated with fireworks noise were given either dexmedetomidine gel (89 dogs) or identical placebo (93 dogs) as needed up to five times, as part of a randomised, double-blinded study.

Owners assessed the overall treatment effects as well as signs and extent of anxiety and fear at several pre-defined time points before and during the New Year's Eve, according to the study protocol.

A higher proportion of dogs were reported to have good or excellent treatment effect in the dexmedetomidine group (64 of 89, 72%) than in the placebo group (34 of 93, 37%) - meaning that the dog did not show any signs of fear and anxiety due to fireworks exposure or the signs were mild and temporary.

Dogs in the dexmedetomidine group displayed fewer signs of fear and anxiety than dogs in the placebo group, despite the noise of fireworks, including panting, trembling, vocalising (whining, barking, growling, howling), pacing and inappropriate urination.

The authors conclude that dexmedetomidine "significantly reduced behaviours related to fear and anxiety over time, and the overall effect and success of treatment were found superior to placebo." Furthermore, they say the dose used was "safe and devoid of any significant clinical sedative effect."

Finally, the novel administration form and delivery system was found by owners to be easy to use across the range of dogs tested, they add, but would like to remind veterinarians of the importance of instructing the clients carefully on correct use of new medications.

The authors would also like to emphasise that a personalised treatment plan should be set up for every patient covering all appropriate treatment options.

Orion Pharma license the dexmedetomidine oromucosal gel to Zoetis, which supply it in the UK to veterinarians.


Related Placebo Articles from Brightsurf:

Effect of fluvoxamine vs placebo on clinical deterioration in outpatients with symptomatic COVID-19
This randomized trial compares the effects of fluvoxamine, a selective serotonin reuptake inhibitor with immunomodulatory effects, versus placebo on a composite of dyspnea or pneumonia and oxygen desaturation among adult outpatients with polymerase chain reaction-confirmed mild COVID-19 illness.

Hydroxychloroquine no more effective than placebo in preventing COVID-19
Clinical trial with COVID-19 testing of participants shows health care workers in contact with coronavirus patients who took hydroxychloroquine each day did not reduce their rate of infection.

Compared to placebo, vitamin D has no benefit for severe asthma attacks
Contrary to earlier observational results, vitamin D supplements do not prevent severe asthma attacks in at-risk children, according to the first placebo-controlled clinical trial to test this relationship.

UMN trial shows hydroxychloroquine has no benefit over placebo in preventing COVID-19
Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19.

The placebo effect and psychedelic drugs: tripping on nothing?
A new study from McGill suggests that, in the right context, some people may experience psychedelic-like effects from placebos alone.

Methotrexate reduces joint damage progression over placebo in erosive hand OA
According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis, but did significantly reduce the progression of joint damage over placebo and seems to facilitate bone remodeling in these patients.

Botulinum toxin reduces chronic migraine attacks, compared to placebo
A growing body of evidence supports the effectiveness of botulinum toxin injections in reducing the frequency of chronic migraine headaches, concludes an updated review and analysis in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Opioids vs. placebo, nonopioid alternatives for chronic noncancer pain
An estimated 50 million adults in the United States were living with chronic noncancer pain in 2016 and many of them were prescribed opioid medications, even though a clinical benefit is uncertain.

Probiotic no better than placebo for acute gastroenteritis in children
While probiotics are often used to treat acute gastroenteritis (also known as infectious diarrhea) in children, the latest evidence shows no significant differences in outcomes, compared to a placebo.

Most common shoulder operation is no more beneficial than placebo surgery
In a landmark study published this week in the BMJ, Finnish researchers show that one of the most common surgical procedures in the Western world is probably unnecessary.

Read More: Placebo News and Placebo Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to